🇺🇸 FDA
Patent

US 10751347

Compositions comprising acidic extracts of mastic gum and uses thereof for treating optic neuropathy

granted A61KA61K2236/33A61K31/19

Quick answer

US patent 10751347 (Compositions comprising acidic extracts of mastic gum and uses thereof for treating optic neuropathy) held by REGENERA PHARMA LTD. expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERA PHARMA LTD.
Grant date
Tue Aug 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2236/33, A61K31/19, A61K31/56, A61K31/568